As of June 12, 2025, AvivaSA Emeklilik ve Hayat AS's estimated intrinsic value ranges from $6.83 to $7.28 per share, depending on the valuation methodology applied.
Valuation Method | Fair Value (USD) | Implied Upside/Downside |
---|---|---|
Dividend Discount Model (Multi-Stage) | $7.28 | -71.6% |
Dividend Discount Model (Stable) | $6.83 | -73.3% |
Is AvivaSA Emeklilik ve Hayat AS (AVISA.IS) undervalued or overvalued?
With the current market price at $25.60, the stock appears to be significantly overvalued.
Intrinsic value represents the "true" worth of a company based on its fundamentals rather than market sentiment. We've employed multiple methodologies to triangulate AvivaSA Emeklilik ve Hayat AS's intrinsic value, including:
The cost of capital is a critical factor in valuation models, representing the required return for investors.
WACC Component | Low | High |
---|---|---|
Long-term bond rate | 21.4% | 21.9% |
Equity market risk premium | 10.2% | 11.2% |
Adjusted beta | 0.65 | 0.73 |
Cost of equity | 27.9% | 30.5% |
Cost of debt | 5.0% | 5.0% |
Tax rate | 22.7% | 23.2% |
Debt/Equity ratio | 0.01 | 0.01 |
After-tax WACC | 27.8% | 30.3% |
The DDM values a company based on its expected future dividend payments. We used two approaches:
Metric | Value |
---|---|
Market Capitalization | $4608M |
Enterprise Value | $3722M |
Trailing P/E | 12.12 |
Forward P/E | 13.27 |
Trailing EV/EBITDA | 0.00 |
Current Dividend Yield | 277.84% |
Dividend Growth Rate (5Y) | 34.01% |
Debt-to-Equity Ratio | 0.01 |
To determine the most reliable intrinsic value estimate, we weigh each valuation method based on:
Valuation Method | Weight | Weighted Value |
---|---|---|
Dividend Discount Model (Multi-Stage) | 57% | $1.46 |
Dividend Discount Model (Stable) | 43% | $1.02 |
Weighted Average | 100% | $7.09 |
Based on our comprehensive valuation analysis, AvivaSA Emeklilik ve Hayat AS's weighted average intrinsic value is $7.09, which is approximately 72.3% below the current market price of $25.60.
Key investment considerations:
Given these factors, we believe AvivaSA Emeklilik ve Hayat AS is currently significantly overvalued with the potential for long-term appreciation based on the company's growth trajectory and financial strength.